Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...

Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

Detailed price information for Exlservice Holdings (EXLS-Q) from The Globe and Mail including charting and trades.

William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

In CCC v AAC [2025] HKCFI 2987, Sir William Blair, sitting as Deputy High Court Judge in the Hong Kong Court of First Instance (“Court”), rejected ...

William Blair analyst Matt Larew maintained a Hold rating on Amedisys today. The company’s shares closed yesterday at $97.52. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and ...

After beating quarterly earnings expectations and raising its full-year sales outlook from a previously forecast decline, ...

Mastercard eased concerns about a potential slowdown in consumer spending after beating Wall Street estimates for ...